| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |